Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | GHSR | Q92847 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30764720 | 0.93 | SIGMAR1 (0.60) | L3MBTL1SMN1; SMN2MAPTSIGMAR1ALDH1A1 | |
| SCHEMBL30764731 | 0.91 | HSD11B1 (0.56) | SMN1; SMN2MAPTALDH1A1HSD11B1 | |
| SCHEMBL30764719 | 0.89 | SMN1; SMN2 (0.53) | SMN1; SMN2MAPTSIGMAR1ALDH1A1HSD11B1 | |
| SCHEMBL30764734 | 0.85 | KMT2A (0.54) | HSD11B1 | |
| SCHEMBL30764728 | 0.82 | SIGMAR1 (0.60) | SMN1; SMN2MAPTSIGMAR1ALDH1A1HSD11B1 | |
| SCHEMBL30764736 | 0.81 | HSD11B1 (0.49) | SIGMAR1HSD11B1CACNA1G | |
| SCHEMBL30764704 | 0.79 | KMT2A (0.54) | L3MBTL1SMN1; SMN2SIGMAR1ALDH1A1HSD11B1 | |
| SCHEMBL30764756 | 0.76 | HSD11B1 (0.47) | MAPTALDH1A1HSD11B1 | |
| SCHEMBL30764737 | 0.76 | HSD11B1 (0.46) | L3MBTL1SMN1; SMN2ALDH1A1HSD11B1HPGD | |
| SCHEMBL17101993 | 0.75 | CYP3A4 (0.55) | L3MBTL1SMN1; SMN2ALDH1A1HSD11B1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568968-A1 | (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | Remynd N.V. (BE) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024033479-A1 | (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | REMYND N.V. (BE) | 2024-02-15 | — | — | WO | disclosed |